ROBERT WADLEY: Open Payments
NPI 1184703332 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 37 payments from 10 companies in 2025. Trend: 2023 $586 · 2024 $1,180 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 11 | $229 |
| Braeburn Inc. | 6 | $147 |
| Valinor Pharma, LLC | 5 | $109 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $73 |
| Forte Bio-Pharma LLC | 3 | $72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| Indivior Inc. | 2 | $62 |
| SCILEX PHARMACEUTICALS INC. | 2 | $34 |
| Abbott Laboratories | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: Belbuca, BRIXADI, MOVANTIK, JOURNAVX, RELISTOR, SUBLOCADE, PROLATE, ZTLido.
Industry payments across NC — which companies pay providers there.
